trial

Targeted Intervention Study of DTMS on Impaired Insight in Early Psychosis

NCTId NCT04513132
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2025-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2024-01-01
Primary completion
2025-12-31
Eligibility
ALL · 15 Years · 35 Years

Interventions & indications

Drugs
active-dTMS
Indications
Impaired Insight

Sponsors

Shanghai Mental Health CenterLead Sponsor

Investigators

2
Jijun Wang, DoctoralStudy Chair
Tianhong Zhang, DoctoralStudy Director

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2025-12-31
Status
WITHDRAWN
relationships
The graph out of here
drug
active-dTMS
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Impaired Insight
indication
investigator
Jijun Wang, Doctoral
person
Tianhong Zhang, Doctoral
person